Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS
Authors:
- Natalia PapaleoNPNatalia Papaleo
- Andrea Molina-AlvarezAMAndrea Molina-Alvarez
- Ricard OnievaRORicard Onieva
- Diana FuertesDFDiana Fuertes
- Blanca Sanchez-GonzalezBSBlanca Sanchez-Gonzalez
- Xenia RieraXRXenia Riera
- David Lopez-SeguraDLDavid Lopez-Segura
- Carmen Lome-MaldonadoCLCarmen Lome-Maldonado
- Xavier Ara-ManceboXAXavier Ara-Mancebo
- Jose YelamosJYJose Yelamos
- Marta SalidoMSMarta Salido
- Ivonne VazquezIVIvonne Vazquez
Open Access
Abstract
Background: LMO2 is a relevant gene involved in B-cell ontogeny and a survival predictor of aggressive large B-cell lymphomas (aLBCL). Most studies assessing LMO2 mRNA expression have relied on microarray platforms or qRT-PCR methods, overlooking tissue morphology. In this study, we evaluate LMO2 RNA expression by chromogenic in situ hybridization (CISH) in normal tissue and in a series of 82 aLBCL. Methods: LMO2 CISH was performed in formalin-fixed paraffin-embedded tissues, scored by three different methods, and correlated with a transcriptome panel. Results: We obtained statistically significant results correlating the methods of evaluation with LMO2 protein expression and gene expression results. Normal tonsil tissue showed high levels of LMO2, particularly within the light zone of the germinal center. Conversely, in aLBCL, a notable reduction in LMO2 expression was noted, remarkably in cases carrying MYC rearrangements. Furthermore, significant results were obtained through overall survival and Cox regression survival analysis, incorporating International Prognostic Index data alongside LMO2 expression levels. Conclusions: We show a reliable method to identify LMO2 mRNA expression by CISH, effectively capturing many of the reported biologic features of LMO2.Keywords
Funding Information
- Fondo de Investigacion Sanitaria (FIS), Instituto de Salud Carlos III (PI17/313, PI23/199)
This publication has 33 references indexed in Scilit:
- An atlas of cells in the human tonsilImmunity, 2024
- Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphomaVirchows Archiv, 2023
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsLeukemia, 2022
- LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stageLaboratory Investigation, 2022
- Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomasVirchows Archiv, 2021
- LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLCancer Cell, 2019
- The proto-oncogene MYC is required for selection in the germinal center and cyclic reentryNature Immunology, 2012
- The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centersNature Immunology, 2012
- RNAscopeThe Journal of Molecular Diagnostics, 2012
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000